-- China released guidelines to optimize pricing for newly marketed and innovative medicines, Xinhua News Agency reported Tuesday.
The General Office of the State Council's guidelines will help ensure patients have access to high-quality and reasonably priced medicines, the report said.
China's guidelines for high-level innovative drugs should be priced according to their high research and development investment and high risk involved for a certain period, according to the state-owned news agency.